Full Text Journal Articles by
Author Juan M Aranda

Advertisement

Find full text journal articles






Functional heart recovery in an adult mammal, the spiny mouse.

Yanfei Qi, Osama Dasa, Malcolm Maden, Ravneet Vohra, Abhinandan Batra, Glenn Walter, Joshua F Yarrow, Juan M Aranda, Mohan K Raizada, Carl J Pepine,

<h4>Background</h4>Ischemic heart disease and the resulting heart failure continue to carry high morbidity and mortality, and a breakthrough in our understanding of this disorder is needed. The adult spiny mouse (Acomys cahirinus) has evolved the remarkable capacity to regenerate full-thickness skin tissue, including microvasculature and cartilage, without fibrosis or scarring. ... Read more >>

Int J Cardiol (International journal of cardiology)
[2021, 338:196-203]

Cited: 2 times

View full text PDF listing >>



Cardiac sarcoidosis in the donor heart without extracardiac manifestations.

Mohammad Al-Ani, Mohamad Badie Taha, Brian D Stewart, Gabrielle S Graves, Mustafa M Ahmed, Alex M Parker, Juan M Aranda, Juan Vilaro,

A middle-aged woman who received heart transplantation for end-stage sarcoid cardiomyopathy developed recurrent cardiac sarcoidosis in the donor heart. She presented 5 years post-transplantation with heart block and systolic dysfunction, without extracardiac involvement. Her disease was unresponsive to corticosteroids. Routine functional imaging may help identify such recurrences. ... Read more >>

BMJ Case Rep (BMJ case reports)
[2021, 14(4):]

Cited: 0 times

View full text PDF listing >>



Advertisement

Erratum to "Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era" AmJMed, 133(11); 1254-1261.

Michael R Massoomi, R David Anderson, Mustafa M Ahmed, Osama Dasa, Philip George, William M Miles, Juan M Aranda, Carl J Pepine,

Am J Med (The American journal of medicine)
[2021, 134(4):555]

Cited: 0 times

View full text PDF listing >>



Ventricular Assist Device Implantation and Bariatric Surgery: A Route to Transplantation in Morbidly Obese Patients with End-Stage Heart Failure.

Eric I Jeng, Amber H Miller, Jeffrey Friedman, Stephen A Tapia-Ruano, Kevin Reilly, Alex Parker, Juan Vilaro, Juan M Aranda, Charles T Klodell, Thomas M Beaver, George J Arnaoutakis, Mustafa Ahmed,

We reviewed our experience of morbidly obese patients with end-stage heart failure that underwent left ventricular assist device (LVAD) implantation. From January 1, 2008 to January 1, 2018, 240 adult LVADs were implanted at our center. We reviewed the cases of patients presenting with end-stage heart failure and morbid obesity ... Read more >>

ASAIO J (ASAIO journal (American Society for Artificial Internal Organs : 1992))
[2021, 67(2):163-168]

Cited: 0 times

View full text PDF listing >>



Patterns of emergency department utilization for LVAD patients compared with non-LVAD patients.

Mohammad Al-Ani, Sarah S Gul, Abhishek Khatri, Muhammad Abdul Baker Chowdhury, Matthew Drabin, Travis Murphy, Brandon Allen, Juan M Aranda, Juan Vilaro, Eric I Jeng, George J Arnaoutakis, Alex M Parker, Lauren E Meece, Mustafa M Ahmed,

<h4>Background</h4>Left ventricular assist device (LVAD) patients are vulnerable to over-utilization of resources.<h4>Methods and results</h4>We explored the pattern of emergency department (ED) presentations of LVAD patients and their costs compared with non-LVAD heart failure patients. ED visits between 7/2008 and 7/2017 were reviewed to identify 145 LVAD patients, and 435 patients ... Read more >>

Int J Cardiol Heart Vasc (International journal of cardiology. Heart & vasculature)
[2020, 30:100617]

Cited: 0 times

View full text PDF listing >>



Hemodynamic effects of ivabradine use in combination with intravenous inotropic therapy in advanced heart failure.

Mohammed Elzeneini, Juan M Aranda, Mohammad Al-Ani, Mustafa M Ahmed, Alex M Parker, Juan R Vilaro,

Intravenous inotropic therapy can be used in patients with advanced heart failure, as palliative therapy or as a bridge to cardiac transplantation or mechanical circulatory support, as well as in cardiogenic shock. Their use is limited to increasing cardiac output in low cardiac output states and reducing ventricular filling pressures ... Read more >>

Heart Fail Rev (Heart failure reviews)
[2021, 26(2):355-361]

Cited: 0 times

View full text PDF listing >>



Reply: Advantage of leadless pacemaker over the conventional pacemaker in patients with left ventricular assist device.

Alex M Parker, Juan R Vilaro, Juan M Aranda, Mohammad Al-Ani, Phillip George, Mustafa M Ahmed,

Pacing Clin Electrophysiol (Pacing and clinical electrophysiology : PACE)
[2020, 43(10):1218]

Cited: 0 times

View full text PDF listing >>



Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era.

Michael R Massoomi, R David Anderson, Mustafa M Ahmed, Osama Dasa, Philip George, William M Miles, Juan M Aranda, Carl J Pepine,

It is clear that existing cardiovascular disease is a major risk factor for COVID-19 and related adverse outcomes. In addition to acute respiratory syndrome, a large cohort also develop myocardial or vascular dysfunction, in part from inflammation and renin angiotensin system activation with increased sympathetic outflow, cardiac arrhythmias, ischemia, heart ... Read more >>

Am J Med (The American journal of medicine)
[2020, 133(11):1254-1261]

Cited: 0 times

View full text PDF listing >>



Severe COVID-19 After Recent Heart Transplantation Complicated by Allograft Dysfunction.

Juan Vilaro, Mohammad Al-Ani, Diana Gomez Manjarres, Jorge E Lascano, Kartik Cherabuddi, Akram Y Elgendy, Mark S Bleiweiss, Alex M Parker, Mustafa M Ahmed, Juan M Aranda,

A 50-year-old male presented with atrial flutter 25 days after heart and kidney transplantation. Rejection was excluded, but he developed severe COVID-19 infection with cardiac allograft dysfunction. Despite continued corticosteroid and tacrolimus therapy, he remained aviremic. Respiratory and myocardial functions recovered after a week of mechanical ventilation. The cardiomyopathy was stress ... Read more >>

JACC Case Rep (JACC. Case reports)
[2020, 2(9):1347-1350]

Cited: 8 times

View full text PDF listing >>



Leadless pacemaker use in a patient with a durable left ventricular assist device.

Alex M Parker, Juan R Vilaro, Juan M Aranda, Mohammad Al-Ani, Phillip George, Mustafa M Ahmed,

There is limited known safety and efficacy of leadless pacemaker device use in patients with durable left ventricular assist devices (LVADs). We present a case of a pacemaker-dependent LVAD patient with infection of permanent transvenous pacemaker who underwent successful implantation of Micra transcatheter pacing system (Medtronic). ... Read more >>

Pacing Clin Electrophysiol (Pacing and clinical electrophysiology : PACE)
[2020, 43(9):1048-1050]

Cited: 0 times

View full text PDF listing >>



Utilizing the index for mortality prediction after cardiac transplantation risk score to predict hospital resource consumption.

Eric I Jeng, David J Hall, Juan Vilaro, Paul Lipori, Alex Parker, Mustafa Ahmed, Juan M Aranda, Tomas D Martin, Thomas M Beaver, George J Arnaoutakis,

OBJECTIVE:The index for mortality prediction after cardiac transplantation (IMPACT) risk score incorporates 12 preoperative recipient-specific variables, and has been validated as an accurate predictor of short- and long-term mortality after orthotopic heart transplantation (OHTx). We believe it can also be used to predict hospital costs, and we hypothesize that higher ... Read more >>

J Card Surg (Journal of cardiac surgery)
[2020, 35(4):854-859]

Cited: 0 times

View full text PDF listing >>



Outpatient Intravenous Diuretic Therapy for Acute Heart Failure: A Simplified Solution to a Formidable Problem.

Mohammad A Al-Ani, Cody Schwartz, David Winchester, Julia Barry, Martin Cerda, Juan M Aranda, Mustafa M Ahmed,

J Card Fail (Journal of cardiac failure)
[2020, 26(9):800-801]

Cited: 2 times

View full text PDF listing >>



Effects of socioeconomic status on clinical outcomes with ventricular assist devices.

Mustafa M Ahmed, Stephen M Magar, Eric I Jeng, George J Arnaoutakis, Thomas M Beaver, Juan Vilaro, Charles T Klodell, Juan M Aranda,

<h4>Background</h4>Lower socioeconomic status (SES) is a known risk factor for worse outcomes after major cardiovascular interventions. Furthermore, individuals with lower SES face barriers to evaluation for advanced heart failure therapies, including ventricular assist device (VAD) implantation.<h4>Hypothesis</h4>Examination of the effects of individual determinants of SES on VAD outcomes will show similar ... Read more >>

Clin Cardiol (Clinical cardiology)
[2018, 41(11):1463-1467]

Cited: 2 times

View full text PDF listing >>



Ventricular Assist Device Patients Have Different Clinical Outcomes and Altered Patterns of Bleeding with Intracranial Hemorrhage.

Mustafa M Ahmed, Maryam Rahman, Dan Neal, Juan M Aranda, Charles T Klodell,

Intracranial hemorrhage (ICH) is one of the most feared complications of left ventricular assist device (LVAD) support. However, outcomes in this group have not been well described. We therefore sought to examine clinical outcomes in this patient population in comparison to those with heart failure (HF) and no LVAD, as ... Read more >>

ASAIO J (ASAIO journal (American Society for Artificial Internal Organs : 1992))
[2018, 64(4):e55-e60]

Cited: 2 times

View full text PDF listing >>



Left Ventricular Assist Device and Bariatric Surgery: A Bridge to Heart Transplant by Weight and Waiting Time Reduction.

Eric I Jeng, Juan M Aranda, Mustafa Ahmed, Charles T Klodell,

Obesity poses significant challenges in advanced heart failure patients who otherwise meet criteria for listing for heart transplant. We present a patient who underwent bariatric surgery while on LVAD support that subsequently lost weight and was successfully bridged to heart transplantation. ... Read more >>

J Card Surg (Journal of cardiac surgery)
[2016, 31(2):120-122]

Cited: 6 times

View full text PDF listing >>



Factors Related to Pump Thrombosis With the Heartmate II Left Ventricular Assist Device.

Charles T Klodell, H Todd Massey, Robert M Adamson, David A Dean, Douglas A Horstmanshof, John M Ransom, Christopher T Salerno, Jennifer A Cowger, Juan M Aranda, Leway Chen, James W Long, Walter Dembitsky,

<h4>Background</h4>Recent reports suggested that HeartMate II (HMII) thrombosis rates may be higher in implants after 2011. We characterize events at HMII centers (>100 HMII implants) whose device thrombosis rates are equivalent or lower than reported by INTERMACS.<h4>Methods</h4>Seven centers pooled implants from 2011 through June 2013 to examine pump thrombus and ... Read more >>

J Card Surg (Journal of cardiac surgery)
[2015, 30(10):775-780]

Cited: 9 times

View full text PDF listing >>



Association Between Bendopnea and Key Parameters of Cardiopulmonary Exercise Testing in Patients With Advanced Heart Failure.

Alberto Dominguez-Rodriguez, Jennifer T Thibodeau, Pedro Abreu-Gonzalez, Colby R Ayers, Alejandro Jimenez-Sosa, Juan M Aranda, Mark H Drazner,

J Card Fail (Journal of cardiac failure)
[2016, 22(2):163-165]

Cited: 7 times

View full text PDF listing >>



Impact of antibiotics on arterial blood pressure in a patient with resistant hypertension - A case report.

YanFei Qi, Juan M Aranda, Vermali Rodriguez, Mohan K Raizada, Carl J Pepine,

Int J Cardiol (International journal of cardiology)
[2015, 201:157-158]

Cited: 30 times

View full text PDF listing >>



The impact of frailty in older patients with non-ischaemic cardiomyopathy after implantation of cardiac resynchronization therapy defibrillator.

Alberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez, Alejandro Jimenez-Sosa, Julia Gonzalez, Natalia Caballero-Estevez, Felisa Vanesa Martín-Casañas, Antonio Lara-Padron, Juan M Aranda,

<h4>Aims</h4>Frailty status impacts the prognosis in older patients with heart disease. However, frailty status impact is unknown in patients with non-ischaemic cardiomyopathy after cardiac resynchronization therapy (CRT).<h4>Methods and results</h4>Functional measures of baseline frailty and clinical data were collected for all patients with non-ischaemic cardiomyopathy before CRT defibrillator (CRT-D) implantation. The ... Read more >>

Europace (Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology)
[2015, 17(4):598-602]

Cited: 22 times

View full text PDF listing >>



Close antiplatelet therapy monitoring and adjustment based upon thrombelastography may reduce late-onset bleeding in HeartMate II recipients.

Ashkan Karimi, Thomas M Beaver, Philip J Hess, Tomas D Martin, Edward D Staples, Richard S Schofield, James A Hill, Juan M Aranda, Charles T Klodell,

<h4>Objectives</h4>Bleeding is the most common complication of HeartMate II and is partially attributable to platelet dysfunction; however, antiplatelet therapy is arbitrary in most centres. We investigated how antiplatelet therapy adjustment with thrombelastography affects late-onset bleeding.<h4>Methods</h4>Thrombelastography was used to adjust antiplatelet therapy in 57 HeartMate II recipients. Kaplan-Meier survival curves and ... Read more >>

Interact Cardiovasc Thorac Surg (Interactive cardiovascular and thoracic surgery)
[2014, 18(4):457-465]

Cited: 9 times

View full text PDF listing >>



Drug-eluting stents may not reduce target lesion revascularization in cardiac allograft vasculopathy.

Ki E Park, Tianyao Huo, Keith E Muller, Juan M Aranda, James A Hill, R David Anderson,

OBJECTIVE: Although drug-eluting stent (DES) compared with bare metal stent (BMS) use reduces in-stent restenosis (ISR) in traditional coronary artery disease, its efficacy in cardiac allograft vasculopathy (CAV) has not been clearly established. BACKGROUND: CAV is a leading cause of mortality after the first year following cardiac transplantation. CAV treatment ... Read more >>

J Interv Cardiol (Journal of interventional cardiology)
[2014, 27(1):80-85]

Cited: 4 times

View full text PDF listing >>



The use of left ventricular assist devices in the treatment of class IV heart failure patients: what the non-heart failure specialist needs to know.

Mustafa Ahmed, Juan M Aranda, Richard S Schofield, Jessica M Bell, Jana A Reid, Charles T Klodell,

The New York Heart Association class IV heart failure patient represents a very sick patient population with a poor 6-month survival rate. With appropriate selection and timing, left ventricular assist devices can provide improved outcomes while these patients are supported for bridge to heart transplant or destination therapy. As the ... Read more >>

Cardiol Rev (Cardiology in review)
[2013, 21(1):37-41]

Cited: 1 time

View full text PDF listing >>



Randomized controlled trial of ventricular elastic support therapy in the treatment of symptomatic heart failure: rationale and design.

William T Abraham, Inder Anand, Juan M Aranda, John Boehmer, Maria Rosa Costanzo, Teresa DeMarco, Richard Holcomb, Russell Ivanhoe, Michael Kolber, Barry Rayburn,

<h4>Background</h4>Despite the current drug and device therapies, heart failure remains associated with high rates of disability, morbidity, and mortality. There is a need for newer therapies. One investigational approach is the use of ventricular support devices. These devices reduce ventricular wall stress leading to decreases in left ventricular (LV) volumes, ... Read more >>

Am Heart J (American heart journal)
[2012, 164(5):638-645]

Cited: 3 times

View full text PDF listing >>



Elective noncardiac surgery in patients with left ventricular assist devices.

Mustafa Ahmed, Houng Le, Juan M Aranda, Charles T Klodell,

As the number of heart failure patients supported with left ventricular assist devices (LVAD) increases, the frequency of elective, noncardiac surgery in this patient population will similarly rise. We retrospectively analyzed our LVAD patient database and identified six patients who underwent elective, noncardiac surgery while on LVAD support. These cases ... Read more >>

J Card Surg (Journal of cardiac surgery)
[2012, 27(5):639-642]

Cited: 17 times

View full text PDF listing >>



[Anticoagulation in atrial fibrillation: new therapeutic alternatives].

Juan M Aranda,

The fundamental treatment of atrial fibrillation is based on maintenance of sinus rhythm or control of ventricular rate and preventing arterial thromboembolism. Warfarin has been the anti-thrombotic agent of choice for the last 50 years. However multiple interactions with other drugs and certain types of food and vegetables with high ... Read more >>

Bol Asoc Med P R (Boletin de la Asociacion Medica de Puerto Rico)
[2012, 104(4):64-65]

Cited: 0 times

View full text PDF listing >>



Advertisement


Disclaimer

0.9358 s